Answers are grounded in this paper and cite their sources.
Androgen Deprivation Therapy (ADT) has been the standard treatment for patients with metastatic prostate cancer. Treatment response is usually of short duration and evolves to a state of metastatic castration-resistant prostate cancer (mCRPC).
No takes yet. Share an insight, caveat, or question.
Bruno Jorge Pereira (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: